Skip to main content

Table 2 Proportion of the population screened within three years by age group

From: Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary

Age group (years)

Percentage screened

12-17

0%

18

32%

21

52%

24

62%

27

65%

30

66%

33

66%

36

63%

39

61%

42

56%

45

53%

48

51%

51

50%

54

49%

57

40%

60

36%

63

32%

66

27%

69

22%

>69

0%